Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-01-10 @ 9:39 AM
Study NCT ID:
NCT00225056
Status:
TERMINATED
Last Update Posted:
2007-04-20
First Post:
2005-09-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
Sponsor:
Organization: